- ONC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
BeiGene (ONC) 8-K22 Jun 22BeiGene Announces Acceptance of Supplemental Biologics License Application in China for Anti-PD-1 Inhibitor TislelizumabFinancial data
Company Profile